Generally, this meta-analysis is conducted through obtaining results from the limited randomized controlled trials (RCTs) based on LCKDs as adjuvant therapy on cancer patients and analyzing the results for the significance towards lipid profile, body weight, fasting blood glucose, insulin, tumor markers, ketosis, adverse events, and satisfaction levels of the patients. The gene discussed is INS; the disease is cancer.